Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies.

ABSTRACT:

SUBMITTER: Deng Z 

PROVIDER: S-EPMC10106261 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature